Reply to the letter to the editor

DOI: 10.4244/EIJ-D-23-00857

Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

Gerald S. Werner1, MD, PhD; David Hildick-Smith2, MD; for the EuroCTO trial investigators.

The author of the letter expresses concerns about percutaneous coronary intervention (PCI) for chronic total coronary occlusions (CTO)1. The author cites a “very high” complication rate in studies that compared successful and unsuccessful CTO PCI procedures. Failed procedures are associated with higher complication rates than successful procedures, certainly, and indeed the randomised EuroCTO study confirms this observation. We found a significant increase in complication rates after failed procedures, but successful procedures resulted in outcomes that were better than with medical management2.

The author comments that in US community hospitals, complication rates for CTO PCI are higher than for non-CTO lesions3. This is not surprising. CTO PCI is a highly complex procedure and, when undertaken by non-specialist operators, has a lower procedural success rate and a higher complication rate. There is a clear relationship between volume and outcome4. CTO PCI is not a routine procedure to be performed by any operator in every institution. It requires training, experience, and familiarity with dedicated equipment and techniques. Indeed the EuroCTO club has emphasised the need for dedicated CTO PCI...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 1
Jan 1, 2024
Volume 20 Number 1
View full issue


Key metrics

Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
38.95

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved